FDA approves first-ever vaccine for respiratory syncytial virus (RSV) for older adults
Dubai, United Arab Emirates (CNN) — After a 60-year scientific career, the world now has the first vaccine to prevent respiratory syncytial virus (RSV), and more vaccines are under study. On Wednesday, the US Food and Drug Administration approved Arexvy, manufactured by GlaxoSmithKline (GSK), designed to be given as a single dose to adults over … Read more